Health and Healthcare
Health and Healthcare Articles
Seattle Genetics shares jumped on Monday after the firm announced positive results from its midstage breast cancer trial.
Published:
Last Updated:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
Last Updated:
Over the past four years, the economic cost of the opioid epidemic has cost the United States some $631 billion. And with more deaths possible, the costs could soar.
Published:
Axsome Therapeutics shares made a handy gain on Wednesday after the firm announced that it has completed patient enrollment in its Gemini study, a Phase 3 trial of AXS-05 in patients with major...
Published:
Achillion Pharmaceuticals shares skyrocketed on Wednesday morning on news that the firm would be acquired by Alexion Pharmaceuticals.
Published:
Last Updated:
Reata Pharma shares jumped on Tuesday after the firm announced positive results from its midstage neuromuscular disorder drug trial.
Published:
Johnson & Johnson reported better than expected quarterly results before the markets opened on Tuesday.
Published:
Last Updated:
UnitedHealth reported better than expected third-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
UnitedHealth is set to release its third-quarter financial results before the markets open on Tuesday, and analysts are looking for year-on-year growth on the top and bottom lines.
Published:
Last Updated:
Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday, and analysts' expectations are mild overall.
Published:
Last Updated:
Allergan has finally announced that its shareholders have voted to approve the company’s acquisition of AbbVie. The acquisition is expected to close in early 2020, but it is still subject to...
Published:
Last Updated:
Flexion Therapeutics has announced that the FDA needs additional time to complete the review of its osteoarthritis knee pain treatment.
Published:
Ra Pharmaceuticals shares more than doubled on Thursday after the announcement that UCB would acquire the firm.
Published:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data has been compared with the previous report, and short interest in...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.